Icares Medicus Inc

Chart & Performance

D1W1MN

P/E

826.83

P/S

2.24

EPS

0.09

Div Yield, %

0.37%

Shrs. gr., 5y

-41.38%

Rev. gr., 5y

25.54%

Revenues

1.13b

+31.54%

Net income

-97.02%

CFO

-59m

L+443.54%

Dividend

Aug 22, 20250.27273 TWD/sh

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

ICARES Medicus, Inc. operates as a dedicated nano-medical materials company, engaging in the entire lifecycle from innovation and production to global distribution of advanced ophthalmic medical materials. Its core offerings encompass a range of ocular solutions, most notably intraocular lenses (IOLs) designed to correct visual impairments such as cataracts, nearsightedness (myopia), farsightedness (hyperopia), age-related vision loss (presbyopia), and astigmatism. Additionally, the company supplies sophisticated surgical implantation systems along with comprehensive technical support services. Established in 2011, ICARES Medicus, Inc. maintains its headquarters in Zhubei, Taiwan.

URL

https://www.icaresmedicus.com/

IPO date

Dec 27, 2016

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title TWD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title TWD in thousands, except ratios and share amounts	2025‑12	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT